Pub Date : 2025-09-02DOI: 10.1016/j.rec.2025.06.012
Julia Rey-Brandariz, Carla Guerra-Tort, Ana Teijeiro, Lucía Rodríguez-Loureiro, Mónica Pérez-Ríos
{"title":"Perceptions of the Spanish population regarding various public health measures to control tobacco use.","authors":"Julia Rey-Brandariz, Carla Guerra-Tort, Ana Teijeiro, Lucía Rodríguez-Loureiro, Mónica Pérez-Ríos","doi":"10.1016/j.rec.2025.06.012","DOIUrl":"10.1016/j.rec.2025.06.012","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145001504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.rec.2025.07.008
Alberto Domínguez-Rodríguez , Daniel Hernández-Vaquero , Néstor Baéz-Ferrer
{"title":"The invisible threat: air pollution is now the second leading risk factor for mortality in the general population","authors":"Alberto Domínguez-Rodríguez , Daniel Hernández-Vaquero , Néstor Baéz-Ferrer","doi":"10.1016/j.rec.2025.07.008","DOIUrl":"10.1016/j.rec.2025.07.008","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 128-130"},"PeriodicalIF":4.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.rec.2025.05.015
David Calvo
{"title":"Registries of the Heart Rhythm Association of the Spanish Society of Cardiology: current role and future prospects","authors":"David Calvo","doi":"10.1016/j.rec.2025.05.015","DOIUrl":"10.1016/j.rec.2025.05.015","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 12","pages":"Pages 1113-1114"},"PeriodicalIF":4.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.rec.2025.07.007
Francisco Javier García-Fernández , Rocío Cózar-León , Josep Navarro-Manchón , Manuel Molina-Lerma , David Calvo , on behalf of the collaborators of the Spanish pacemaker registry
Introduction
This report presents data on cardiac pacing system implants in Spain during 2024.
Methods
The registry is based on data voluntarily submitted by implanting centers to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online platform, CardioDispositivos. Additional data sources included: a) data provided by device manufacturers and distributors, b) the European pacemaker patient card, and c) local databases submitted by implanting centers.
Results
A total of 128 hospitals submitted data to the registry (16 more than in 2023 and 46 more than in 2022). In total, 26 412 units were reported (an 8.5% increase compared with 2023 and 60.8% compared with 2022), vs 47 162 units reported by Eucomed (European Confederation of Medical Suppliers Associations). Among these, 1715 were cardiac resynchronization pacemakers. Leadless pacemaker use continued to rise (1049 devices), accounting for 2.2% of all pacemakers. The most common indication was atrioventricular block, followed by atrial tachyarrhythmia with slow ventricular response. Devices included in remote monitoring also increased: the most notable growth was observed in high-energy resynchronization devices (87%) and leadless pacemakers (38%). Moderate increases were also noted for conventional cardiac resynchronization pacemakers (59%) and standard pacemakers (39%).
Conclusions
Participation in the pacemaker registry continues to grow, reaching 56% of the number of units reported by manufacturers to Eucomed. Remote monitoring maintains the slow but steady growth trend observed in recent years.
{"title":"Spanish pacemaker registry. 22nd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2024)","authors":"Francisco Javier García-Fernández , Rocío Cózar-León , Josep Navarro-Manchón , Manuel Molina-Lerma , David Calvo , on behalf of the collaborators of the Spanish pacemaker registry","doi":"10.1016/j.rec.2025.07.007","DOIUrl":"10.1016/j.rec.2025.07.007","url":null,"abstract":"<div><h3>Introduction</h3><div>This report presents data on cardiac pacing system implants in Spain during 2024.</div></div><div><h3>Methods</h3><div>The registry is based on data voluntarily submitted by implanting centers to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online platform, <em>CardioDispositivos</em>. Additional data sources included: <em>a)</em> data provided by device manufacturers and distributors, <em>b)</em> the European pacemaker patient card, and <em>c)</em> local databases submitted by implanting centers.</div></div><div><h3>Results</h3><div>A total of 128 hospitals submitted data to the registry (16 more than in 2023 and 46 more than in 2022). In total, 26 412 units were reported (an 8.5% increase compared with 2023 and 60.8% compared with 2022), vs 47 162 units reported by Eucomed (European Confederation of Medical Suppliers Associations). Among these, 1715 were cardiac resynchronization pacemakers. Leadless pacemaker use continued to rise (1049 devices), accounting for 2.2% of all pacemakers. The most common indication was atrioventricular block, followed by atrial tachyarrhythmia with slow ventricular response. Devices included in remote monitoring also increased: the most notable growth was observed in high-energy resynchronization devices (87%) and leadless pacemakers (38%). Moderate increases were also noted for conventional cardiac resynchronization pacemakers (59%) and standard pacemakers (39%).</div></div><div><h3>Conclusions</h3><div>Participation in the pacemaker registry continues to grow, reaching 56% of the number of units reported by manufacturers to Eucomed. Remote monitoring maintains the slow but steady growth trend observed in recent years.</div></div>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 12","pages":"Pages 1076-1087"},"PeriodicalIF":4.9,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-27DOI: 10.1016/j.rec.2025.08.001
Margarida G. Figueiredo, José Miguel Viegas, Sílvia Aguiar Rosa
{"title":"Hypertrophic cardiomyopathy with sequential intracavitary obstruction resolved by mavacamten","authors":"Margarida G. Figueiredo, José Miguel Viegas, Sílvia Aguiar Rosa","doi":"10.1016/j.rec.2025.08.001","DOIUrl":"10.1016/j.rec.2025.08.001","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 187-188"},"PeriodicalIF":4.9,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19DOI: 10.1016/j.rec.2025.06.011
Raquel Campuzano , Julio Núñez , Violeta Sánchez , Juan José Gómez-Doblas , Vicente Arrarte , Ángel Cequier , Blanca Miranda , Cristina Fernández , Náyade Prado , Nicolás Rosillo , José Luis Bernal , Pablo Pérez , Sonia Gutiérrez , Jordi Bañeras
Introduction and objectives
Atherosclerotic vascular disease is the main cause of mortality attributable to air pollution. This study analyzes, for the first time, the association between levels of fine particulate matter (PM2.5, particles ≤ 2.5 μm in diameter) and hospital admissions and in-hospital mortality due to acute myocardial infarction (AMI) in hospitals of the Spanish National Health System.
Methods
Data on air pollution, temperature, and humidity were obtained from the Ministry for the Ecological Transition and the Demographic Challenge, covering the period from 2016 to 2021. A total of 122 National Health System hospitals were geographically matched with environmental monitoring stations located within a 10 km radius. The study included 115 071 patients aged 18 years or older (mean age, 67 years; 28% women) who were discharged with a diagnosis of AMI during the study period. An autoregressive integrated moving average (ARIMA) model was applied to each hospital, and a meta-analysis was conducted to consolidate the estimates of the association between PM2.5 levels and variations in AMI hospital admissions. The association between PM2.5 pollution and in-hospital AMI mortality was analyzed using logistic regression models.
Results
Maximum 3-day average PM2.5 levels exceeding 10 μg/m3 were associated with an additional 21.9 AMI hospital admissions per 1000 (95%CI, 9.1-34.8; P < .001). Furthermore, PM2.5 levels above 25 μg/m3 (3-day moving average) were associated with an increased risk of in-hospital mortality due to AMI (OR, 1.14; 95%CI, 1.07-1.23; P < .001).
Conclusions
This study identifies a significant association between elevated PM2.5 levels and increased hospital admissions and in-hospital mortality due to AMI in Spain, highlighting the importance of reducing air pollution as a critical factor in cardiovascular health.
{"title":"Impact of fine particulate matter (PM2.5) pollution on hospital admissions and mortality due to acute myocardial infarction in Spain","authors":"Raquel Campuzano , Julio Núñez , Violeta Sánchez , Juan José Gómez-Doblas , Vicente Arrarte , Ángel Cequier , Blanca Miranda , Cristina Fernández , Náyade Prado , Nicolás Rosillo , José Luis Bernal , Pablo Pérez , Sonia Gutiérrez , Jordi Bañeras","doi":"10.1016/j.rec.2025.06.011","DOIUrl":"10.1016/j.rec.2025.06.011","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Atherosclerotic vascular disease is the main cause of mortality attributable to air pollution. This study analyzes, for the first time, the association between levels of fine particulate matter (PM<sub>2.5</sub>, particles ≤ 2.5<!--> <!-->μm in diameter) and hospital admissions and in-hospital mortality due to acute myocardial infarction (AMI) in hospitals of the Spanish National Health System.</div></div><div><h3>Methods</h3><div>Data on air pollution, temperature, and humidity were obtained from the Ministry for the Ecological Transition and the Demographic Challenge, covering the period from 2016 to 2021. A total of 122 National Health System hospitals were geographically matched with environmental monitoring stations located within a 10<!--> <!-->km radius. The study included 115 071 patients aged 18 years or older (mean age, 67 years; 28% women) who were discharged with a diagnosis of AMI during the study period. An autoregressive integrated moving average (ARIMA) model was applied to each hospital, and a meta-analysis was conducted to consolidate the estimates of the association between PM<sub>2.5</sub> levels and variations in AMI hospital admissions. The association between PM<sub>2.5</sub> pollution and in-hospital AMI mortality was analyzed using logistic regression models.</div></div><div><h3>Results</h3><div>Maximum 3-day average PM<sub>2.5</sub> levels exceeding 10<!--> <!-->μg/m<sup>3</sup> were associated with an additional 21.9 AMI hospital admissions per 1000 (95%CI, 9.1-34.8; <em>P</em> <!--><<!--> <!-->.001). Furthermore, PM<sub>2.5</sub> levels above 25<!--> <!-->μg/m<sup>3</sup> (3-day moving average) were associated with an increased risk of in-hospital mortality due to AMI (OR, 1.14; 95%CI, 1.07-1.23; <em>P<!--> </em><<!--> <!-->.001).</div></div><div><h3>Conclusions</h3><div>This study identifies a significant association between elevated PM<sub>2.5</sub> levels and increased hospital admissions and in-hospital mortality due to AMI in Spain, highlighting the importance of reducing air pollution as a critical factor in cardiovascular health.</div></div>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 117-127"},"PeriodicalIF":4.9,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144972793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-14DOI: 10.1016/j.rec.2025.06.010
Rafael de la Espriella
{"title":"Refractory congestion in heart failure: when standard therapies fall short","authors":"Rafael de la Espriella","doi":"10.1016/j.rec.2025.06.010","DOIUrl":"10.1016/j.rec.2025.06.010","url":null,"abstract":"","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"78 11","pages":"Pages 1007-1009"},"PeriodicalIF":4.9,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-13DOI: 10.1016/j.rec.2025.07.005
Marco Vitolo , Marco Proietti , Marta Mantovani , Jacopo Francesco Imberti , Davide Antonio Mei , Niccolò Bonini , Giulio Francesco Romiti , Bernadette Corica , Igor Diemberger , Laurent Fauchier , Francisco Marín , Gheorghe-Andrei Dan , Tatjana S. Potpara , Gregory Y.H. Lip , Giuseppe Boriani
Introduction and objectives
Increased physical activity may improve outcomes in patients with atrial fibrillation (AF), but available data are limited. This study aimed to analyze the association between physical activity and major adverse outcomes in a large European AF cohort.
Methods
We used data from a prospective, observational, large-scale multicenter study of AF in European patients, involving 27 countries and 250 centers. Patients self-reported their physical activity levels during the preceding 2 years, categorized as none (physically inactive), occasional, regular, or intense. The primary outcome was a composite of major adverse cardiovascular (CV) events and all-cause mortality.
Results
A total of 9525 patients with AF were included (median age 71 years; 41% female). Overall, 43% reported being physically inactive. Among those who reported physical activity, 56.9% described it as occasional, 36.5% as regular, and 6.6% as intense. Inactive patients had a higher burden of both CV and non-CV comorbidities. Over a median follow-up of 728 days, 16.2% of the patients experienced the primary composite endpoint. Physical activity was independently associated with a lower risk of the primary endpoint (adjusted HR, 0.68; 95% CI, 0.59-0.76), with a progressively lower incidence as activity levels increased. Interaction analyses showed that the beneficial effect of physical activity was consistent among several subgroups, with no significant interactions.
Conclusions
Physical activity, even at low levels, was associated with a reduced incidence of CV events and all-cause mortality. These benefits appear to be independent of CV risk factors and comorbidities, highlighting the importance of incorporating physical activity into holistic AF management strategies.
{"title":"Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort","authors":"Marco Vitolo , Marco Proietti , Marta Mantovani , Jacopo Francesco Imberti , Davide Antonio Mei , Niccolò Bonini , Giulio Francesco Romiti , Bernadette Corica , Igor Diemberger , Laurent Fauchier , Francisco Marín , Gheorghe-Andrei Dan , Tatjana S. Potpara , Gregory Y.H. Lip , Giuseppe Boriani","doi":"10.1016/j.rec.2025.07.005","DOIUrl":"10.1016/j.rec.2025.07.005","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Increased physical activity may improve outcomes in patients with atrial fibrillation (AF), but available data are limited. This study aimed to analyze the association between physical activity and major adverse outcomes in a large European AF cohort.</div></div><div><h3>Methods</h3><div>We used data from a prospective, observational, large-scale multicenter study of AF in European patients, involving 27 countries and 250 centers. Patients self-reported their physical activity levels during the preceding 2 years, categorized as none (physically inactive), occasional, regular, or intense. The primary outcome was a composite of major adverse cardiovascular (CV) events and all-cause mortality.</div></div><div><h3>Results</h3><div>A total of 9525 patients with AF were included (median age 71 years; 41% female). Overall, 43% reported being physically inactive. Among those who reported physical activity, 56.9% described it as occasional, 36.5% as regular, and 6.6% as intense. Inactive patients had a higher burden of both CV and non-CV comorbidities. Over a median follow-up of 728 days, 16.2% of the patients experienced the primary composite endpoint. Physical activity was independently associated with a lower risk of the primary endpoint (adjusted HR, 0.68; 95% CI, 0.59-0.76), with a progressively lower incidence as activity levels increased. Interaction analyses showed that the beneficial effect of physical activity was consistent among several subgroups, with no significant interactions.</div></div><div><h3>Conclusions</h3><div>Physical activity, even at low levels, was associated with a reduced incidence of CV events and all-cause mortality. These benefits appear to be independent of CV risk factors and comorbidities, highlighting the importance of incorporating physical activity into holistic AF management strategies.</div></div>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":"79 2","pages":"Pages 151-164"},"PeriodicalIF":4.9,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-13DOI: 10.1016/j.rec.2025.07.006
Jun Hao, Jingyang Wang, Rui Shi, Qi Wang, Xiaohua Cheng, Jiayu Feng, Yanmin Yang, Yuxiao Hu, Tao Chen, Kangyu Chen
Introduction and objectives: Resting heart rate is a readily available vital sign with important prognostic significance. However, traditional measures overlook both the magnitude and duration of elevated heart rate over time. This study assessed the association between cumulative resting heart rate load and adverse outcomes in patients with chronic heart failure (HF) in sinus rhythm.
Methods: Data from 5 randomized controlled trials (BEST, GUIDE-IT, HF-ACTION, RELAX, and TOPCAT) were analyzed. Cumulative heart rate load was calculated as the area under the curve (AUC) for heart rate ≥70 beats per minute (bpm), relative to the total AUC prior to outcomes. The primary outcome was major adverse cardiac events (MACE), defined as the composite of cardiovascular death and hospitalization for HF. Cox proportional hazards regression models were used to examine associations with outcomes.
Results: A total of 5428 patients were included. Higher cumulative resting heart rate load was significantly associated with increased risk of MACE (hazard ratio [HR], 1.31; 95% CI, 1.24-1.38), cardiovascular death (HR, 1.17; 95% CI, 1.08-1.27), hospitalization for HF (HR, 1.34; 95% CI, 1.26-1.43), all-cause death (HR, 1.20; 95% CI, 1.12-1.29), and any hospitalization (HR, 1.20; 95% CI, 1.15-1.25). Cumulative resting heart rate load demonstrated superior predictive value for all outcomes compared with baseline heart rate, mean heart rate, heart rate standard deviation, and heart rate time in the target range with improvements in C-statistics, net reclassification improvement, and integrated discrimination improvement when added to base models.
Conclusions: Cumulative resting heart rate load provides stronger prognostic value for adverse outcomes in chronic HF. Incorporating this parameter into clinical practice may improve risk stratification and help identify high-risk patients who could benefit from intensive monitoring or therapeutic interventions.
{"title":"Cumulative resting heart rate load and cardiovascular risk in patients with heart failure in sinus rhythm.","authors":"Jun Hao, Jingyang Wang, Rui Shi, Qi Wang, Xiaohua Cheng, Jiayu Feng, Yanmin Yang, Yuxiao Hu, Tao Chen, Kangyu Chen","doi":"10.1016/j.rec.2025.07.006","DOIUrl":"10.1016/j.rec.2025.07.006","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Resting heart rate is a readily available vital sign with important prognostic significance. However, traditional measures overlook both the magnitude and duration of elevated heart rate over time. This study assessed the association between cumulative resting heart rate load and adverse outcomes in patients with chronic heart failure (HF) in sinus rhythm.</p><p><strong>Methods: </strong>Data from 5 randomized controlled trials (BEST, GUIDE-IT, HF-ACTION, RELAX, and TOPCAT) were analyzed. Cumulative heart rate load was calculated as the area under the curve (AUC) for heart rate ≥70 beats per minute (bpm), relative to the total AUC prior to outcomes. The primary outcome was major adverse cardiac events (MACE), defined as the composite of cardiovascular death and hospitalization for HF. Cox proportional hazards regression models were used to examine associations with outcomes.</p><p><strong>Results: </strong>A total of 5428 patients were included. Higher cumulative resting heart rate load was significantly associated with increased risk of MACE (hazard ratio [HR], 1.31; 95% CI, 1.24-1.38), cardiovascular death (HR, 1.17; 95% CI, 1.08-1.27), hospitalization for HF (HR, 1.34; 95% CI, 1.26-1.43), all-cause death (HR, 1.20; 95% CI, 1.12-1.29), and any hospitalization (HR, 1.20; 95% CI, 1.15-1.25). Cumulative resting heart rate load demonstrated superior predictive value for all outcomes compared with baseline heart rate, mean heart rate, heart rate standard deviation, and heart rate time in the target range with improvements in C-statistics, net reclassification improvement, and integrated discrimination improvement when added to base models.</p><p><strong>Conclusions: </strong>Cumulative resting heart rate load provides stronger prognostic value for adverse outcomes in chronic HF. Incorporating this parameter into clinical practice may improve risk stratification and help identify high-risk patients who could benefit from intensive monitoring or therapeutic interventions.</p>","PeriodicalId":38430,"journal":{"name":"Revista española de cardiología (English ed.)","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144859746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号